414-IGLL5+ B细胞破坏三级淋巴结构并抑制肿瘤免疫回复 episode artwork

EPISODE · Jan 22, 2026 · 18 MIN

414-IGLL5+ B细胞破坏三级淋巴结构并抑制肿瘤免疫回复

from 聊聊Sci

这项发表在《Cancer Cell》上的研究揭示了IGLL5+ B细胞子集在膀胱癌及多种癌症中破坏三级淋巴结构(TLS)并导致免疫治疗耐药的机制。研究人员通过单细胞测序和空间转录组技术发现,此类B细胞通过IGLL5-LTβR配体-受体相互作用锚定于高内皮静脉(HEVs),进而抑制其非经典NF-κB信号通路,导致HEV功能障碍和TLS解体。这种结构的破坏阻碍了效应CD8+ T细胞的激活,使肿瘤产生免疫逃逸。临床实验表明,使用IGLL5中和抗体可有效恢复TLS形成,显著增强免疫检查点阻断疗法的疗效。该成果为攻克肿瘤免疫治疗耐药提供了全新的治疗靶点和策略。References: Chen C, An M, Zheng H, et al. B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity[J]. Cancer Cell, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jan 22, 2026

Embed this episode

Ready to play

414-IGLL5+ B细胞破坏三级淋巴结构并抑制肿瘤免疫回复

0:00 18:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 18 minutes long.

When was this 聊聊Sci episode published?

This episode was published on January 22, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!